The fact: Stripe, Anthropic, and OpenAI have jointly launched a fund to finance research into preventing respiratory infections — including the common cold. The initiative, called the Respiratory Health Initiative, starts with $50 million. Stripe founders Patrick and John Collison contribute the first $10 million. Anthropic and OpenAI provide AI tools and models to accelerate molecule discovery and predictive modeling.
Why it matters: This is not just tech philanthropy. It's a sign that US big tech is colonizing traditionally public sectors — healthcare. For Stripe, the cold isn't a direct business, but controlling healthcare payment platforms is. For OpenAI and Anthropic, every clinical dataset is gold. Europe? Watching again. While Silicon Valley decides where to pour billions in R&D, the Old Continent struggles between GDPR and bureaucratic inertia. Result: Italian SMEs — already struggling with digital transformation — remain dependent on US-controlled tech and data.
Sponsored Protocol
Our position is clear: Europe cannot afford to be a spectator.
We at Meteora Web see it daily: our clients in Southern Italy use Stripe for payments, OpenAI APIs for chatbots, American analytics tools. And that's fine — they're excellent. But when a private consortium sets global health research priorities, European public interests risk being sidelined. The AI Act is good, but not enough. Without a European health-AI research fund that competes with these giants, our companies will remain consumers, not creators. In digital health, data is the new oil. If they control it, we'll pay forever for the fuel.
Sponsored Protocol
What to do: If you work in digital health or run an Italian SME using AI tools for healthcare, ask your vendors: where is health data processed? Who owns the models? Choose platforms that guarantee data sovereignty (e.g., certified European clouds). Support initiatives like the European Health Data Space. Above all: don't wait for someone else to decide. Digital autonomy is built one integration at a time.
